264 related articles for article (PubMed ID: 33831779)
1. Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatments of Alzheimer's disease: A comprehensive review.
Jin X; Guo JL; Wang L; Zhong X; Yao WF; Gao H; Liu MY
Eur J Med Chem; 2021 Jun; 218():113401. PubMed ID: 33831779
[TBL] [Abstract][Full Text] [Related]
2. Potential therapeutic agents against Alzheimer's disease from natural sources.
Park SY
Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
[TBL] [Abstract][Full Text] [Related]
3. Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatment of diabetes and its complications: An update since 2010.
Lin QR; Jia LQ; Lei M; Gao D; Zhang N; Sha L; Liu XH; Liu YD
Pharmacol Res; 2024 Feb; 200():107054. PubMed ID: 38181858
[TBL] [Abstract][Full Text] [Related]
4. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Natural Products for Alzheimer's Disease.
Chen X; Drew J; Berney W; Lei W
Cells; 2021 May; 10(6):. PubMed ID: 34070275
[TBL] [Abstract][Full Text] [Related]
7. Recent Progress in the Drug Development for the Treatment of Alzheimer's Disease Especially on Inhibition of Amyloid-peptide Aggregation.
Liu Y; Cong L; Han C; Li B; Dai R
Mini Rev Med Chem; 2021; 21(8):969-990. PubMed ID: 33245270
[TBL] [Abstract][Full Text] [Related]
8. An Insight in Pathophysiological Mechanism of Alzheimer's Disease and its Management Using Plant Natural Products.
Firdaus Z; Singh TD
Mini Rev Med Chem; 2021; 21(1):35-57. PubMed ID: 32744972
[TBL] [Abstract][Full Text] [Related]
9. Role of natural products for the treatment of Alzheimer's disease.
Noori T; Dehpour AR; Sureda A; Sobarzo-Sanchez E; Shirooie S
Eur J Pharmacol; 2021 May; 898():173974. PubMed ID: 33652057
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer's disease.
Reddy PH; Manczak M; Yin X; Grady MC; Mitchell A; Kandimalla R; Kuruva CS
J Investig Med; 2016 Dec; 64(8):1220-1234. PubMed ID: 27521081
[TBL] [Abstract][Full Text] [Related]
11. Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury - A potential therapeutic agent for Alzheimer's Disease.
Ponne S; Kumar CR; Boopathy R
Metab Brain Dis; 2020 Mar; 35(3):503-515. PubMed ID: 31691145
[TBL] [Abstract][Full Text] [Related]
12. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G
Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757
[TBL] [Abstract][Full Text] [Related]
13. Small molecules as therapeutic drugs for Alzheimer's disease.
Oliver DMA; Reddy PH
Mol Cell Neurosci; 2019 Apr; 96():47-62. PubMed ID: 30877034
[TBL] [Abstract][Full Text] [Related]
14. Natural Products Targeting Amyloid Beta in Alzheimer's Disease.
Lee JH; Ahn NH; Choi SB; Kwon Y; Yang SH
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652858
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of Nrf2/Keap1/ARE in Alzheimer's Disease by Plant Secondary Metabolites: A Mechanistic Review.
Fakhri S; Pesce M; Patruno A; Moradi SZ; Iranpanah A; Farzaei MH; Sobarzo-Sánchez E
Molecules; 2020 Oct; 25(21):. PubMed ID: 33114450
[TBL] [Abstract][Full Text] [Related]
16. Natural Products in Alzheimer's Disease Therapy: Would Old Therapeutic Approaches Fix the Broken Promise of Modern Medicines?
Habtemariam S
Molecules; 2019 Apr; 24(8):. PubMed ID: 30999702
[TBL] [Abstract][Full Text] [Related]
17. Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer's Disease.
Nesi G; Sestito S; Digiacomo M; Rapposelli S
Curr Top Med Chem; 2017; 17(27):3062-3079. PubMed ID: 28595557
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential.
Mi Y; Qi G; Brinton RD; Yin F
Antioxid Redox Signal; 2021 Mar; 34(8):611-630. PubMed ID: 32143551
[No Abstract] [Full Text] [Related]
19. Small Molecule Natural Products and Alzheimer's Disease.
Wu X; Cai H; Pan L; Cui G; Qin F; Li Y; Cai Z
Curr Top Med Chem; 2019; 19(3):187-204. PubMed ID: 30714527
[TBL] [Abstract][Full Text] [Related]
20. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
